U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890702) titled 'Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease' on March 17.
Brief Summary: The goal of this single-center prospective observational study is to identify and evaluate new biomarkers for ischemic cerebrovascular disease (ICVD) to aid in early diagnosis, individualized treatment planning, and prognosis prediction in affected patients. The main questions it aims to answer are:
Can specific biomarkers help in identifying high-risk individuals before disease onset? Can these biomarkers predict disease progression and treatment response? Researchers will compare patients diagnosed with ICVD and healthy contro...